BLOOMINGTON– Lilly Endowment Inc., through the eighth phase of its Giving Indiana Funds for Tomorrow (GIFT VIII) initiative, has awarded a $7,834,000 Community Leadership ...
With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Early reaction was mostly positive Thursday to a Senate GOP priority bill that seeks to increase oversight of water ...
An online threat has been made against the 100th anniversary of the Chincoteague Pony Swim, a summer event that draws ...
The measure would require a utility or large private-sector project leader to obtain an approval permit before carrying out a ...
Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic response rates in patients with Crohn disease. The FDA has ...
Eli Lilly is also investing in its manufacturing networks to support the production of next-generation AOMs, demonstrating a long-term commitment to this therapeutic area. Eli Lilly's future growth is ...
Eli Lilly is also investing in its manufacturing networks to support the production of next-generation AOMs, demonstrating a long-term commitment to this therapeutic area. Eli Lilly's future ...
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback